Page 65 - Merck Sharp News Today

Lucknow, July 13, 2022: MSD Pharmaceuticals Pvt. Ltd., a wholly owned subsidiary of Merck Sharp & Dohme (known as Merck & Co., Inc. in the United States and Canada) and Smile Foundation today announced the launch of three Smile on Wheels Mobi

BERLIN--(BUSINESS WIRE)--Regulatory News:NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the resignation of Gregory Weaver from its Supervisory Board, effective September 30,...

Many patients with advanced ovarian cancer may be eligible for first-line maintenance with a PARP inhibitor, research suggests.

BERLIN--(BUSINESS WIRE)--Regulatory News:NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that pursuant to the liquidity contract entrusted to Invest Securities by NOXXON Phar...

The #hpvsearchkiyakya is a public awareness campaign to educate about HPV prevention

Public awareness of COVID antiviral drugs is so poor that a pharmaceutical company has launched a multimillion-dollar campaign to boost their uptake.

AutoThis is the first of many disease awareness communication campaigns launched with a focus on educating and sensitizing young adult females about the consequences associated with HPV infections. It will go one step further by giving the audiences

Seven NCI sponsored trials will evaluate safety and efficacy of its BET inhibitor (BETi) ZEN-3694 in combination with several targeted agents and/or...

LUND, SWEDEN / ACCESSWIRE / June 28, 2022 / BioInvent International (STO:BINV)Lund, Sweden - June 28, 2022 - BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused

Researchers are conducting a phase 1 trial of nab-paclitaxel and pembrolizumab in patients with hormone receptor-positive breast cancer.